Antiphospholipid antibodies (aPL) represent an important risk factor for thrombosis and recurrent miscarriage in patients with antiphospholipid syndrome (APS). The mechanisms of aPLmediated pregnancy failure have been researched. Previous studies demonstrated that aPL bind trophoblast cells, reducing proliferation, human chorionic gonadotrophin release, and in vitro invasiveness. Recent data suggest that aPL are also able to react with human decidual cells, inducing a proinflammatory phenotype. Decidua, a newly formed tissue on the maternal side of the human placenta, is characterized by active angiogenesis and structural modifications of the spiral arteries in early pregnancy. Since angiogenesis is a critical component of normal placentation, the purpose of our study was to evaluate the role of aPL on human endometrial angiogenesis. For this reason, we investigated the effect of aPL on in vitro endometrial endothelial cell (HEEC) angiogenesis, VEGF secretion by ELISA, matrix metalloproteinases (MMPs) activity by gelatin zymography, and DNA binding activity of NFKB by a sensitive multiwell colorimetric assay. Furthermore, we performed experiments to study whether aPL affects in vivo angiogenesis in a murine model. We found that aPL significantly decrease the number and the total length of the tubules formed by HEEC on in vitro Matrigel assay and reduce newly formed vessels in aPL-inoculated mice. Moreover, aPL reduce significantly both VEGF and MMPs production and, at the nuclear level, NFKB DNA binding activity. From our results, it appears that aPL are associated with an inhibition of angiogenesis, suggesting further additional mechanisms to explain the defective placentation in the APS.
INTRODUCTION
Antiphospholipid syndrome (APS) is defined as the persistent presence of antiphospholipid antibodies (aPL) associated with recurrent thrombotic events and/or fetal loss [1] [2] [3] [4] . There is evidence that aPL are pathogenic, but placental thrombosis cannot explain all the fetal losses, and an aPL-mediated inhibition of trophoblast invasion has been suggested as one of the mechanisms for APS complications [5] . Recent data suggest that aPL are also able to react with human stromal decidual cells: polyclonal aPL bind to decidual cells in monolayer and induce a proinflammatory phenotype [6] . Altogether, these studies support a cause-effect relationship between aPL and recurrent fetal loss.
The decidua is newly formed tissue on the maternal side of human placenta characterized by active angiogenesis and structural modifications of the spiral arteries. In the context of the pregnant uterus, critical angiogenic signals are likely to be produced by the decidualizing endometrial cells acting on the endothelial cells to promote their proliferation and differentiation. After stimulation of the endothelial cells by angiogenic factors, the basement membrane is degraded by proteolytic enzymes, in particular matrix-degrading metalloproteinases (MMPs). The cells then invade, migrate, and proliferate into the underlying interstitial matrix and form new capillary structures [7, 8] . Angiogenesis together with steroid hormones induce the changes in the endometrium that enable it to accept the blastocyst and initiate the process of implantation. Endometrial angiogenesis and decidualization, as well as trophoblast invasion, are thus prerequisites for successful implantation and the beginning of pregnancy.
Studies have shown organ-specific characteristics among microvascular endothelial cells [9, 10] . Since the endometrium is a tissue unique for its cyclic destruction and rapid generation of blood vessels, the angiogenic behavior of its endothelial cells is expected to differ from that of the endothelial cells in other tissues. To date, there are only a few reports that describe the isolation and characterization of the endothelial cells of the endometrium [11, 12] .
The present study was set up to test the possibility of a direct effect of aPL on endometrial endothelial cell (HEEC) angiogenesis. With this in mind, we investigated 1) the role of polyclonal aPL on an in vitro three-dimensional system to explore HEEC angiogenesis and 2) whether aPL incubation may modulate VEGF secretion and MMPs activity in HEEC. In addition, we performed experiments to examine whether polyclonal aPL, with beta2-glycoprotein-I (b2-GPI) activity, interfere with in vivo angiogenesis in a murine model.
MATERIALS AND METHODS

Patients
Six patients with primary APS diagnosed according to the Sidney criteria [13, 14] and six control aPL-negative women with no obstetrical problems were studied. The characteristics of the patients are reported in Table 1 . Anticardiolipin (aCL), anti-b2-GPI, and lupus anticoagulant (LAC) were detected as previously described [15, 16] . The study was approved by the human investigation committee of the Catholic University of Sacred Heart. All the patients and control subjects included in the study provided written informed consent.
Human Polyclonal Anti-PL Antibodies
Whole IgG fractions from APS patients and from normal human serum (NHS) were purified on protein G-Sepharose (Mab Trap-GII; Pharmacia-Biotech, Uppsala, Sweden) as previously described [17] . The final protein IgG concentration was evaluated by nephelometry, and the specific reactivity with CL-and b2-GPI-coated plates was confirmed as previously described [17] . The sterile-filtered IgG fractions were determined to be free of endotoxin contamination by the limulus amoebocyte lysate assay (E-Toxate; SigmaAldrich Co., St. Louis, MO) (sensitivity of the assay , 0.03 international units/ ll).
Absorption Experiments
Sera from APS patients were subjected to absorption with CL (0.5 mg/ml) as previously reported [18] . Sera were incubated with CL for 2 h at room temperature and overnight at 48C. After incubation, the mixtures were centrifuged at 30 000 3 g for 15 min and the supernatants kept as adsorbed sera. The samples were tested, before and after absorption, for aCL and anti-b2-GPI antibodies by ELISA (data not shown). After absorption, only negligible background values were detected. Immunoglobulin G fractions from absorbed sera were then purified on protein G-Sepharose [17] .
Tissue Collection
Informed consent was obtained from each patient before surgery. Endometrial tissues were obtained from fertile women undergoing hysterectomy for fibroid uteri and biopsy for benign diseases in the midsecretory phase. The mean age of the patients was 37.4 yr (range 30-42 yr). The day of the menstrual cycle was established from the patient's menstrual history and was verified by a histological examination of the endometrium according to the criteria outlined by Noyes, Hertig, and Rock [19] . Estradiol and progesterone were determined in the serum to confirm the midsecretory phase. The tissues were placed in Hanks balanced salt solution (HBSS; 0.137 M NaCl, 5.4 mM KCI, 0.25 mM Na 2 HPO 4 , 0.44 mM KH 2 PO 4 , 1.3 mM CaCl 2 , 1.0 mM MgSO 4 , and 4.2 mM NaHCO 3 ) and transported to the laboratory for HEEC isolation and culture. Each experimental setup was repeated on at least five occasions using cells obtained from different patients.
Isolation and Purification of Human Endometrial Endothelial Cells
The endometrium was minced and incubated in M199/penicillin/streptomycin (Sigma-Aldrich Co.) containing 0.2% collagenase type II at 378C for 2 h. Adding the same amount of culture medium stopped the reaction, and all the remaining tissue was dissolved by powerful resuspension, resulting in a homogenous solution. After centrifugation (1200 rpm for 5 min at room temperature), the pellet obtained was resuspended in culture medium and transferred into a fibronectin-coated culture dish; the cells that had not adhered were removed 2-4 h later, and the adherent cells were then placed in the hEMVEC (human endometrial microvascular endothelial cells; Sigma-Aldrich Co.) culture medium.
The primary heterogeneous cell population was left to grow until near confluence before selection of the endothelial cells using anti-human CD31-and CD105-coated MicroBeads (Miltenyi Biotec S.r.l, Bo, Italy). Briefly, after detachment using trypsin and centrifugation, the cells were immunolabeled with CD31 and then CD105 MicroBeads (20 ll per 1 3 10 7 cells) before being loaded onto a column placed in the magnetic field of a MACS Separator. The magnetically labeled CD31 þ /CD105 þ cells remained attached to the column.
The unlabeled cells fell away, so this subset of cells was depleted of CD31 þ / CD105 þ cells. After removal of the column from the magnetic field, the magnetically retained CD31
þ cells were eluted as the positively selected cell subset and placed directly into culture or analyzed for purity by flow cytometry.
Flow Cytometry
Characterization of the isolated HEEC was performed by flow cytometry. Aliquots of HEEC were incubated for 15 min at room temperature with specific endothelial markers: FITC (fluorescein isothiocyanate)-or APC (allophycocyanin)-conjugates monoclonal antibodies (MoAbs) and VE-cadherin and/or KDR (R&D System, Abingdon, UK). Appropriate fluorochrome-conjugated isotype-matched irrelevant MoAbs were used as control for background staining. Cells were run through a flow cytometer (FACSCanto; Becton Dickinson, Mountain View, CA). A minimum of 10 000 events were collected, and the data was acquired in list mode with the accompanying software (FACS Diva software; Becton Dickinson). Human umbilical vein endothelial cells (HUVEC) were used as the positive control (data not shown).
Binding of aPL to Human Endothelial Cells
The binding of polyclonal aPL to HEEC membrane surface was detected by immunofluorescence assay and a cell-ELISA. Briefly, HEEC were fixed with 2% paraformaldehyde before incubation with aPL (IgG fractions from APS patients) in PBS for 60 min at room temperature. After being washed twice in PBS, the cells were incubated with anti-human secondary antibody conjugated with fluorescein isothiocyanate (R&D System) [20] . The preparations were then observed under a microscope equipped with a fluorescence lamp (Zeiss Axioscop, Berlin, Germany), and photographs were taken with a Nikon Coolpix digital camera.
A cell-ELISA was performed to determine whether polyclonal aPL bind to HEEC monolayers. Endothelial cell cultures grown to confluence in 96-well microtiter plates were washed three times with HBSS (Flow Laboratories, Irvine, U.K.); 15-60 lg/ml IgG from APS patients and NHS were added to the wells. After a 2-h incubation, followed by three washes, the plates were incubated with alkaline phosphatase-conjugated goat anti-human IgG or IgM (Sigma-Aldrich Co.) for 90 min. After four washes, chromogenic substrate (50 ll of 1 mg/ml p-nitrophenylphosphate in 10% diethanolamine, pH 9.8) was added to each well and incubated for 30 min. The optical density was read at 405 nm (Titertek Multiskan ELISA reader; Labsystem, Helsinki, Finland) as previously described [21] .
In Vitro Angiogenesis Assay
Endothelial cell differentiation into capillary-like tubular structures was monitored by the BD Biocoat angiogenesis system (BD Biosciences, San Jose, CA). HEEC were seeded on Matrigel-coated plates (2 3 10 4 cell/wells) in endothelial cell culture medium (EBM-2) MV SingleQuots (Lonza, Milan, Italy) containing aPL or NHS IgG fractions (15, 30 , and 60 lg/ml) or 40 lM suramin (Calbiochem, San Diego, CA) as a negative control, and incubated for 8-12 h at 378C and 5% CO 2 atmosphere. Following incubation, the plates were washed twice with HBSS, and tubule formation was observed using an inverted phase optical microscope (Olympus IX50; Olympus, Milan, Italy). The number and the total length of the tubules in each well were determined from images acquired with a digital camera (Nikon, Tokyo, Japan) and quantified by Adobe Photoshop software (San Jose, CA).
Gelatin Zymography
MMP2 levels in the supernatant of endometrial endothelial cell cultures were measured by gelatin zymography. Samples were placed on SDSpolyacrylamide gel containing 0.3% gelatin. Following electrophoresis, gels were washed three times for 10 min at room temperature in 2.5% Triton X-100 to remove the SDS. After overnight incubation at 378C in 50 mM Tris-HCl, pH 7.4, containing 5 mM CaCl 2 , 0.15 M NaCl, and 0.02% NaN 3 , gels were stained with 0.5% coomassie brilliant blue for 30 minutes and destained in 20% methanol and 10% acetic acid. Gelatinolytic activities were observed as a clear band of digested gelatin on a blue background. Images were acquired with a digital camera (Nikon, Tokyo, Japan), and bands were analyzed on the Image Analysis System Gel Doc 200 System (Bio-Rad Laboratories, Milan, Italy) using their Quantity One quantitation software.
VEGF Secretion
VEGF secretion was determined by a human VEGF colorimetric ELISA kit (Pierce Endogen, Rockford, IL) according to the manufacturer's instructions. Briefly, HEEC were plated in 24-well plates at 50 000 cells/well in endothelial cell culture medium with 5% fetal bovine serum and 0-60 lg/ml of aPL or NHS IgG fractions, and incubated for 24 h at 378C and 5% CO 2 atmosphere. Culture media or standard (50 ll) was added to each well previously coated with human monoclonal anti-VEGF antibody. After 2 h of incubation, wells were washed and incubated with an enzyme-linked polyclonal anti-VEGF antibody, horseradish peroxidase. 3,3 0 ,5,5 0 -Tetramethyl benzidine substrate solution was added to each well, and the color developed in proportion to the amount of the VEGF bound in the initial step. The plate was read on a Titertek Multiscan plus Mk II plate reader (ICN Flow Laboratories, Irvine, CA) measuring the differential absorbance at wavelengths of 450 nm minus 550 nm.
Angiogenesis by Direct In Vivo Assay
Five-wk-old CD1 female nude mice obtained from an outbred background were purchased from Charles River Laboratory (Calco, Italy). All procedures followed the requirements of Commission Directive 86/609/EEC concerning the protection of animals used for experimental and other scientific purposes. All the experimental procedures were approved by the local ethical committee on preclinical studies. The mice were allowed to acclimate to their new environment for 1 wk after arrival. They were housed in disinfected polycarbonate mouse cages, maintained in a cabinet with laminar flow at 288C under controlled artificial lighting (12L:12D), and given ad libitum access to rodent chow and water during the study. We performed the experiments on groups of 10 animals.
For the angiogenesis assay, the direct in vivo assay (DIVA) kit was used (Trevigen, Inc., Gaithersburg, MD). During the course of the assay, implant silicone cylinders closed at one end, called angioreactors, were filled with Matrigel with or without the angiogenic factor (fibroblast growth factor-2, FGF-2) and different concentrations of polyclonal aPL or NHS IgG fractions (0, 15, 30, and 60 lg/ml). Angioreactors were incubated at 378C for 1 h to allow for gel formation before subcutaneous implantation into the dorsal flank of the mice. In each mouse, two angioreactors were implanted. If they were filled with angiogenic factors, mice vascular endothelial cells migrated and proliferated in the Matrigel to form vessels in the angioreactors. At the end of the experiment, the angioreactors were collected, and new vessel formation was determined by FITC-lectin staining. After staining, the vessels were washed, and the fluorescence was measured in 96 multiwell plates using a spectrofluorometer reader (Twinkle LB 970; Berthold Technologies, BadWilbad, Germany); excitation was at 485 nm, and emission at 510 nm. The mean relative fluorescence 6 SEM for four replicate assays was determined.
Measurement of NFKB DNA Binding Activity
The DNA binding activity of NFKB was measured with a sensitive multiwell colorimetric assay (Transcription Factor Assay kit; Millipore, Temecula, CA). Briefly, HEEC cultured in EBM-2 MV SingleQuots were scraped and centrifuged for 10 min at 1500 rpm. The pellet was resuspended in 100 ll of lysis buffer (10 mM HEPES [pH 7.9], 1.5 mM MgCl 2 , 10 mM KCI, 0.5 mM DTT, 0.1% Triton X-100, and Protease inhibitor Cocktail), and the lysate was centrifuged for 20 min at 15 000 rpm. The remaining pellet contained the nuclear portion of the cell lysate. The nuclear pellet was resuspended in ice-cold nuclear extraction buffer (20 mM HEPES [pH 7.9], 1.5 mM MgCl 2 , 0.42 M NaCl, 0.2 mM EDTA, 0.5 MM DTT, 1.0% Igepal CA-630, 25% (v/v) glycerol, Protease Inhibitor Cocktail) for 30-60 min at 48C and then centrifuged at 16 000 rpm for 5 min. Five microliters of this supernatant (1 lg/ll) from each sample were incubated in 96-well plates coated with NFKB consensus double-stranded oligonucleotide sequence (5 0 -AGTTGAGGG GACTTTCCCAGGC-3 0 ) for 1 h, with primary NFKB antibody (1:500) for 1 h, with peroxidase-conjugated secondary antibody (1:500) for 1 h, and subsequently with peroxidase-conjugated secondary antibody (1:1000) for 1 h at room temperature (Millipore). After the colorimetric reaction, the optical density was read at 450 nm. For competition assays, cell extracts were incubated with 22-bp double-stranded DNA, either wild-type or mutated (5 0 -AGTTGAGCTCACTTTCCCAGGC-3 0 ; underline denotes the substitution).
Statistical Analyses
The results are presented as the mean 6 standard error (SEM). The data were analysed using one-way analysis of variance (ANOVA) followed by a posthoc test (Bonferroni test). Statistical significance was determined at P , 0.05.
RESULTS
Flow Cytometry Analysis
Five different endometrial samples were subjected to CD31 and CD105 cell immunomagnetic isolation by incubation with 
HEEC Binding Activity of the Polyclonal Anti-b2-GPI Antibodies
The immunofluorescence analysis of the HEEC revealed aPL binding on cellular membranes that showed the presence of a fine line surrounding the cells (Fig. 1A) . No reactivity was observed with polyclonal IgG fractions obtained from normal patients (NHS). 
Effect of aPL on Capillary Tube Formation and VEGF Production
To investigate whether aPL affect the ability of HEEC to form capillary-like tubes, cells were cultured in the presence of 15-60 lg/ml b2-GPI-dependent polyclonal aPL IgG (APS I-VI). Cells were seeded in extracellular matrix gels and examined for tube formation microscopically (Fig. 2) . After 18 h of culture, polyclonal aPL IgG induced a significant decrease in number and total length of the tubules (Fig. 3) . To confirm the effect of aPL on angiogenesis, we tested the ability of aPL to modulate the secretion of VEGF, a wellcharacterized angiogenic factor. Our data showed that 15-60 lg/ml b2-GPI-dependent aPL IgG reduced VEGF production in HEEC cells (Table 2) . On the contrary, culture with control polyclonal IgG (NHS I-VI) did not modify capillary tube formation or VEGF production (data not shown).
Antiphospholipid Antibodies Inhibits Endothelial Endometrial MMP2
MMP2 was expressed in HEEC. In order to investigate whether aPL can affect endothelial MMP2 levels, we carried out cell cultures in the presence of polyclonal aPL. Incubation with 15-60 lg/ml polyclonal b2-GPI-dependent aPL IgG (APS I-VI) but not with normal IgG (NHS I-VI) significantly reduced MMP2 protein activities (Fig. 4) .
Systemic Angiogenesis
To study in vivo angiogenesis, two DIVA angioreactors were implanted into the dorsal flanks of mice. Angioreactors were dissected at the end of the experiment, and the new vessels were quantified. The results of the FITC-lectin determination of the murine endothelial cell invasion showed several newly formed vessels that invaded the Matrigel. Measurement of FITC-lectin binding to the murine endothe- These results suggest that b2-GPI-dependent polyclonal aPL IgG inhibited the angiogenesis process in vivo. In contrast, the respective control polyclonal IgG (NHS I, II, and III) did not modify in vivo angiogenesis (data not shown).
Antiphospholipid Antibodies Impairs NFKB Translocation in HEEC
Because NFKB recognizes multiple regulatory elements in the VEGF promoter region and is connected with multiple aspects of angiogenesis, we evaluated whether aPL affected NFKB activation in HEEC. Exposure of HEEC to EBM-2 MV SingleQuots leads to cell differentiation and to a rapid increase in transcription rate of NFKB. Polyclonal b2-GPI-dependent aPL IgG (APS I-VI) but not normal IgG (NHS I-VI) reduced NFKB translocation. The effect was dose dependent and significant (P , 0.05) at the highest concentrations (30-60 lg/ ml; Fig. 6 ). Experiments performed with a 100-fold excess of unlabeled KB oligonucleotide demonstrated the specificity of the DNA binding activity (data not shown).
DISCUSSION
Our results show for the first time that aPL are able to decrease endometrial endothelial cell angiogenesis. Furthermore, in vivo studies confirm that aPL are responsible for a comparable reduction in angiogenesis.
Angiogenesis occurs in a coordinated series of steps. One of the earliest events is the degradation of the vascular basement membrane and the remodeling of the extracellular matrix (ECM). The role of NFKB in the regulation of these systems is well documented: NFKB promotes the expression of several MMPs [22] . MMPs constitute a family of secreted zincdependent endopeptidases that are required for ECM degradation, cell invasion, and angiogenesis. MMP2 and MMP9 have been shown to enhance angiogenesis by helping the detachment of pericytes from vessels, releasing ECM-bound angiogenic factors, exposing cryptic proangiogenic integrin binding sites in the ECM, and cleaving endothelial cell-cell adhesions. MMP2 is the main gelatinase and the key enzyme in trophoblast invasion [23] . It is constitutively secreted by endothelial cells, as is VEGF, which in turn is able to induce expression of the MMPs in endothelial cells [24, 25] .
We evaluated whether aPL might affect the activation of NFKB in HEEC, and we observed that aPL induces a decrease of its DNA binding activity in a dose-dependent manner. The aPL inhibitory effect on NFKB activity is well correlated with the decrease of VEGF secretion, the decrease of MMP2 activity, and the suppression of tube formation. It has been reported that MMPs requires NFKB activation [26] [27] [28] [29] . Therefore, the inhibitory effect of aPL on NFKB protein might be able to explain the suppression of MMP2 activity. Huang et al. [30] reported a NFKB-dependent increase in the expression of VEGF in a metastatic cell line. In other studies, expression of angiogenic genes (i.e., VEGF) was blocked in cells transfected with a dominant-negative IKB expression plasmid [31, 32] . The down-regulation of VEGF gene expression was associated with a decrease in angiogenesis as well as in cellular invasion through a Matrigel matrix in vitro [33] . Altogether these findings support the view that aPL might affect HEEC angiogenesis through NFKB inhibition and, as a consequence, might reduce VEGF production and MMPs activity.
It was previously reported that anti-b2-GPI antibodies increase cytokine secretion and adhesion molecules expression by human endothelial cells [34, 35] . The E-selection upregulation in endothelial cells activated by anti-b2-GPI antibodies was dependent on NFKB translocation [36] [37] [38] . Comparable findings have been reproduced also in in vivo experimental models [39] . In the present study, we demonstrated an inhibitory effect of aPL on NFKB activity in endometrial endothelial cells; this data might seem to contradict previous observations. However, several studies have shown organ-specific characteristics among microvascular endothelial cells [9, 10] . As the endometrium is a tissue unique for its cyclic destruction and rapid generation of blood vessels, the angiogenic behavior of its endothelial cells is expected to differ from that of endothelial cells in other tissues. Furthermore in our model, HEEC is exposed to a specific culture medium (i.e., EBM-2) that contains angiogenic factors able to induce NFKB activation, cell proliferation and migration, and tube formation rate. A previous study [40] found an overexpression of NFKB in angiogenesis and an inhibitory effect on NFKB activity that was well correlated with the suppression of increased angiogenesis. In conclusion, we previously reported that polyclonal antib2-GPI antibodies decrease cytotrophoblast invasiveness [41] and interfere with trophoblast functions. We now show that the same antibodies also decrease endometrial angiogenesis and propose several intracellular mechanisms of action. These observations suggest an autoantibody effect not only on the fetal side of the placenta but also on the maternal one. Altogether these findings further support the view that several pathogenic mechanisms may coexist and act together in establishing the defective placentation associated with aPL [5, 42] .
